IOVA
Iovance Biotherapeutics Inc
12.90$
-0.3%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +4,299.2% | -95.4% | +129.7% | +14.1% | +1,144.8% | +1,032.4% | -2.1% | -2.7% | +0.4% | +749.7% | -86.0% | +1,126.3% | +51.2% | +56.7% | +31.6% | -21.0% | |
| – | – | – | – | – | – | -80.6% | +123.5% | +121.8% | -36.7% | +67.3% | +21.2% | +68.4% | +70.6% | +20.4% | -25.5% | +75.1% | -43.8% | |
| – | – | – | – | -316.4% | – | +273.5% | +123.5% | +121.8% | -36.7% | +67.4% | +19.6% | +70.7% | +70.6% | +21.7% | – | – | – | |
| – | – | – | +1,536.0% | +312.3% | -117.8% | – | – | – | -0.5% | +542.1% | -201.0% | – | +723.1% | -111.8% | – | – | – | |
| – | – | – | – | -100.0% | – | +12,430.7% | -28.2% | +33.1% | -32.4% | +16.5% | +477.4% | +576.5% | -19.7% | -45.6% | +9.1% | -50.3% | +205.7% | |
| – | – | – | – | -100.0% | – | +12,430.7% | +5,625.6% | – | +559.7% | -758.3% | – | -453.1% | – | +194,184.1% | -160.5% | -37.9% | – | |
| – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | -71.4% | +9,114.2% | +53.9% | +120.7% | -100.8% | +95.0% | -82.2% | +39.9% | -9.0% | – | -267.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | -100.0% | – | – | – | |
| – | – | +9,521.3% | +188.1% | -68.5% | +1,248.6% | +51.9% | +120.7% | +23.8% | -39.4% | +623.0% | -98.6% | +9,301.8% | -58.5% | -20.5% | +143.5% | -15.6% | -23.0% | |
| – | – | +23,895.0% | -160.9% | – | – | +28.3% | -223.9% | – | -47.1% | -263.5% | – | – | -78.6% | +1,242.6% | -136.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.